XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

Balance Sheet Components (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents consisted of the following (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Cash |  | $ | 1,730 |  |  | $ | 2,004 |
Commercial paper |  |  | 17,328 |  |  |  | 14,269 |
Money market funds |  |  | 8,063 |  |  |  | 28,241 |
U.S. government bonds |  |  | 6,488 |  |  |  | 5,968 |
Total cash and cash equivalents |  | $ | 33,609 |  |  | $ | 50,482 |
Schedule of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consisted of the following (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Insurance proceeds receivable for litigation settlement |  | $ | — |  |  | $ | 28,500 |
Prepaid assets |  |  | 2,069 |  |  |  | 1,903 |
Other current assets |  |  | 1,257 |  |  |  | 1,139 |
Total prepaid expenses and other current assets |  | $ | 3,326 |  |  | $ | 31,542 |
Schedule of Accrued and Other Current Liabilities | Accrued and other current liabilities consisted of the following (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Preclinical and clinical trial accruals |  | $ | 6,151 |  |  | $ | 6,327 |
API and bulk drug product price true-up |  |  | 13,331 |  |  |  | 13,071 |
Litigation settlement |  |  | — |  |  |  | 28,500 |
Payroll and related accruals |  |  | 4,362 |  |  |  | 4,640 |
Accrued restructuring charge |  |  | 2,583 |  |  |  | 4,572 |
Professional services |  |  | 4,626 |  |  |  | 2,049 |
Current portion of liability related to sale of future revenues |  |  | 1,858 |  |  |  | 460 |
Other |  |  | 2,413 |  |  |  | 2,416 |
Total accrued and other current liabilities |  | $ | 35,324 |  |  | $ | 62,035 |

X
- Definition Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs. + References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration